CoChat

Implications of Oxidative Stress and Homocysteine in the Pathophysiology of Essential Hypertension

Rodrigo, Ramón, Passalacqua, Walter, Araya, Julia, Orellana, Myriam, Rivera, Gonzalo · 2003 · Journal of Cardiovascular Pharmacology
Cited by 85

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

The present review examines the clinical and experimental data to support the view that homocysteine and oxidative stress, two alternative risk factors of vascular disease, may play a role in the pathogenesis of primary or essential hypertension. Although the precise mechanism of this disease has not been elucidated, it may be related to impairment of vascular endothelial and smooth muscle cell function. Thus, the occurrence of endothelial dysfunction could contribute to alterations of the endothelium-dependent vasomotor regulation. Hyperhomocysteinemia limits the bioavailability of nitric oxide, increases oxidative stress, stimulates the proliferation of vascular smooth muscle cells, and alters the elastic properties of the vascular wall. The link between oxidative stress and hyperhomocysteinemia is also biologically plausible, because homocysteine promotes oxidant injury to the endothelium. Cumulated evidence suggests that the diminution of oxidative stress with antioxidants or the correction of hyperhomocysteinemia with vitamins-B plus folic acid, could be useful as an adjuvant therapy for essential hypertension. Further studies involving long-term trials could help to assess the tolerability and efficacy of the use of these therapeutic agents.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/00005344-200310000-00001

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • Role of oxidative stress in cardiovascular diseases

    Dhalla, N. S., Temsah, R. M., & Netticadan, T. (2000) · Journal of Hypertension · doi:10.1097/00004872-200018060-00002 · Cited by 1,467 · cited 1×

    “Cumulative evidence is sufficiently compelling to suggest that antioxidants are potentially therapeutic agents in essential hypertension.(13) At present, it seems appropriate to propose some dietary recommendations with a high antioxidant content (i.”
    Background
  • NF-κB: pivotal mediator or innocent bystander in atherogenesis?

    Collins, T., & Cybulsky, M. I. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10373 · Cited by 727 · cited 2×

    “gen species.(44) In turn, NF- B may contribute to the mitogenic effect of homocysteine by activating cyclin D1 expression(45), thus leading to a marked increase in vascular smooth muscle proliferation, as shown by studies in vitro.”
    Background
  • Role of Angiotensin and Oxidative Stress in Essential Hypertension

    Romero, J. C., & Reckelhoff, J. F. (1999) · Hypertension · doi:10.1161/01.hyp.34.4.943 · Cited by 358 · cited 1×

    “istration of subpressor doses of angiotensin II has remained undefined.(11) It deserves special mention that angiotensin can stimulate superoxidation, which can oxidize arachidonic acid releasing F2-isoprostanes.”
    Background
  • How does ascorbic acid prevent endothelial dysfunction?

    May, J. M. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00269-0 · Cited by 260 · cited 1×

    “However, it is first necessary to determine which of many plausible mechanisms account for the effect, and to ensure that undesirable toxic effects are not present.(99) On the other hand, chronic ingestion of pharmacological doses of vitamin E suppresses the elevation of blood pressure and oxidative stress, with age,…”
    Background

Show all 4 references

Cited by

See all 85

Metadata

Authors
Rodrigo, R., Passalacqua, W., Araya, J., Orellana, M., & Rivera, G.
Venue
Journal of Cardiovascular Pharmacology
Published
2003-10
Volume
42
Issue
4
Pages
453-461
ISSN
0160-2446 (ISSN-L)
OpenAlex
W2028835073
Cited by
85
References
4
FWCI
2.30
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Implications of Oxidative Stress and Homocysteine in the Pathophysiology of Essential Hypertension. https://app.cochat.ai/papers/10.1097/00005344-200310000-00001
The paper
Rodrigo, R., Passalacqua, W., Araya, J., Orellana, M., & Rivera, G. (2003). Implications of Oxidative Stress and Homocysteine in the Pathophysiology of Essential Hypertension. Journal of Cardiovascular Pharmacology. https://doi.org/10.1097/00005344-200310000-00001

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.